… had entered into a development and licensing agreement, governed under British law, with MedImmune in 1995, stemming from a research collaboration that resulted in adalimumab, which AbbVie today sells as the blockbuster drug Humira. The agreement allowed AbbVie to practice the ‘516 patent, …
